文献速递临床生化临床免疫

新型高敏心肌肌钙蛋白I全血检测法性能评估

Evaluation of a novel high sensitivity cardiac troponin I assay with whole blood.
PubMed 文献 · Clin Chim Acta · 2020-05-20

本研究评估了Pylon hs-cTnI检测法在全血、血浆和质控品中的不精密度、定量限及与Abbott Architect hs-cTnI的相关性。结果显示全血检测的分析性能与临床实验室仪器相当,全血定量限为2.0 ng/l,血浆为1.2 ng/l,且血细胞比容在25%至44%范围内不影响全血与血浆的定量相关性。

要点

  • Pylon hs-cTnI全血检测的分析性能与临床实验室仪器相当。
  • 全血定量限(20% CV)为2.0 ng/l,血浆为1.2 ng/l。
  • 血细胞比容在25%至44%范围内不影响全血与血浆的定量相关性。

核心结论

  • Pylon hs-cTnI全血检测的分析性能与临床实验室仪器相当。

研究设计与样本

  • 评估Pylon hs-cTnI检测法在全血、血浆和商品质控品中的不精密度。
  • 确定全血和血浆的定量限(LOQ)。
  • 使用全血和血浆样本评估Pylon hs-cTnI与Abbott Architect hs-cTnI的相关性。

主要发现

  • 混合患者血浆平均浓度为8.3、15.0和396.9 ng/l时,重复性CV分别为7.6%、4.3%和3.3%,实验室内CV分别为9.9%、4.5%和4.5%。
  • LOQ(20% CV)在血浆中为1.2 ng/l,在全血中为2.0 ng/l。
  • 达到10% CV的最低浓度在血浆中为4.8 ng/l,在全血中为9.4 ng/l。
  • 全血与对应血浆样本的定量相关性不受血细胞比容在25%至44%范围内的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-sensitivity cardiac troponin (hs-cTn) assays provide high sensitivity detection of myocardial injury. Although an assay using whole blood can reduce turn-around-time and labour, hs-cTn assays using whole blood samples are novel requiring characterization of their analytical performance. METHODS: The imprecision of Pylon hs-cTnI assay was evaluated with whole blood, plasma and commercial quality control samples. The limit of quantitation (LOQ) of whole blood samples and plasma were determined for the Pylon hs-cTnI assay. The correlation between the Pylon hs-cTnI assay and the Abbott Architect hs-cTnI assay was evaluated using whole blood samples and plasma. RESULTS: The average concentrations of pooled patient plasma were 8.3, 15.0 and 396.9 ng/l, while the corresponding CVs of repeatability and within-laboratory CVs were calculated respectively as 7.6% and 9.9%, 4.3% and 4.5%, and 3.3% and 4.5%. LOQ (20% CV) was 1.2 ng/l in plasma and 2.0 ng/l in whole blood. The lowest concentrations to reach 10% CV were 4.8 ng/l with plasma and 9.4 ng/l with whole blood. Quantification of whole blood and corresponding plasma samples correlated with no effect by hematocrits ranging from 25 to 44%. CONCLUSION: The analytical performance of the Pylon hs-cTnI assay with whole blood is comparable to that of a clinical lab instrument.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Lin YH, Li Y, Su BM, et al. Evaluation of a novel high sensitivity cardiac troponin I assay with whole blood. Clin Chim Acta. 2020. PMID: 32445744. doi:10.1016/j.cca.2020.05.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。